Lupin Limited, commonly referred to as Lupin, is a prominent global player in the pharmaceutical industry, headquartered in Mumbai, India. Founded in 1968, the company has established a strong presence in key operational regions, including North America, Europe, and Asia. Lupin is renowned for its diverse portfolio, which encompasses generic and branded formulations, biotechnology products, and active pharmaceutical ingredients (APIs). With a commitment to innovation, Lupin has achieved significant milestones, including numerous approvals from regulatory authorities worldwide. The company is particularly noted for its leadership in the anti-TB and cardiovascular segments, offering unique products that cater to unmet medical needs. As a result, Lupin has secured a competitive market position, consistently ranking among the top generic pharmaceutical companies globally.
How does Lupin's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Lupin's score of 51 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Lupin reported total greenhouse gas emissions of approximately 61474000 kg CO2e for Scope 1, 263905000 kg CO2e for Scope 2, and 901520000 kg CO2e for Scope 3, amounting to a total of about 1220000000 kg CO2e globally. In 2023, the emissions were approximately 86910000 kg CO2e (Scope 1), 323845000 kg CO2e (Scope 2), and 854936000 kg CO2e (Scope 3), resulting in a total of about 1260000000 kg CO2e. In India, for 2023, Lupin's emissions included approximately 87068000 kg CO2e (Scope 1), 340945000 kg CO2e (Scope 2), and 651664000 kg CO2e (Scope 3), totalling around 428013000 kg CO2e for Scope 1 and 2 combined. The previous year, 2022, saw similar figures with approximately 86175000 kg CO2e (Scope 1), 380306000 kg CO2e (Scope 2), and 676018000 kg CO2e (Scope 3), leading to a combined total of about 466481000 kg CO2e for Scope 1 and 2. Lupin has set an ambitious target to reduce its Scope 1 and Scope 2 greenhouse gas emissions by 15% by 2030, starting from 2021. This commitment reflects the company's proactive approach to addressing climate change and aligns with industry standards for emissions reduction. Additionally, Lupin is a signatory to the Climate Pledge, further demonstrating its commitment to sustainability and climate action.
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 103,887,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 371,883,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 680,968,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Lupin has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Common questions about Lupin's sustainability data and climate commitments